The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society

Diabetes Metab Res Rev. May-Jun 2001;17(3):189-212. doi: 10.1002/dmrr.196.


This review summarises the results and discussions of an UNESCO-MCBN supported symposium on oxidative stress and its role in the onset and progression of diabetes. There is convincing experimental and clinical evidence that the generation of reactive oxygen species (ROI) is increased in both types of diabetes and that the onset of diabetes is closely associated with oxidative stress. Nevertheless there is controversy about which markers of oxidative stress are most reliable and suitable for clinical practice. There are various mechanisms that contribute to the formation of ROI. It is generally accepted that vascular cells and especially the endothelium become one major source of ROI. An important role of oxidative stress for the development of vascular and neurological complications is suggested by experimental and clinical studies. The precise mechanisms by which oxidative stress may accelerate the development of complications in diabetes are only partly known. There is however evidence for a role of protein kinase C, advanced glycation end products (AGE) and activation of transcription factors such as NF kappa B, but the exact signalling pathways and the interactions with ROI remain a matter of discussion. Additionally, results of very recent studies suggest a role for ROI in the development of insulin resistance. ROI interfere with insulin signalling at various levels and are able to inhibit the translocation of GLUT4 in the plasma membrane. Evidence for a protective effect of antioxidants has been presented in experimental studies, but conclusive evidence from patient studies is missing. Large-scale clinical trials such as the DCCT Study or the UKPDS Study are needed to evaluate the long-term effects of antioxidants in diabetic patients and their potential to reduce the medical and socio-economic burden of diabetes and its complications.

Publication types

  • Review

MeSH terms

  • Animals
  • Cardiovascular Diseases / physiopathology
  • Congresses as Topic
  • Diabetes Complications
  • Diabetes Mellitus / physiopathology*
  • Diabetic Angiopathies / physiopathology
  • Diabetic Neuropathies / physiopathology
  • Disease Progression
  • Glycation End Products, Advanced / physiology
  • Humans
  • Oxidative Stress*
  • Reactive Oxygen Species / physiology
  • Transcription Factors / metabolism


  • Glycation End Products, Advanced
  • Reactive Oxygen Species
  • Transcription Factors